201 related articles for article (PubMed ID: 29225186)
1. Hinokitiol inhibits compound action potentials in the frog sciatic nerve.
Magori N; Fujita T; Kumamoto E
Eur J Pharmacol; 2018 Jan; 819():254-260. PubMed ID: 29225186
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by general anesthetic propofol of compound action potentials in the frog sciatic nerve and its chemical structure.
Magori N; Fujita T; Mizuta K; Kumamoto E
Naunyn Schmiedebergs Arch Pharmacol; 2019 Mar; 392(3):359-369. PubMed ID: 30519707
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by menthol and its related chemicals of compound action potentials in frog sciatic nerves.
Kawasaki H; Mizuta K; Fujita T; Kumamoto E
Life Sci; 2013 Mar; 92(6-7):359-67. PubMed ID: 23352972
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by non-steroidal anti-inflammatory drugs of compound action potentials in frog sciatic nerve fibers.
Suzuki R; Fujita T; Mizuta K; Kumamoto E
Biomed Pharmacother; 2018 Jul; 103():326-335. PubMed ID: 29665554
[TBL] [Abstract][Full Text] [Related]
5. Compound action potential inhibition produced by various antidepressants in the frog sciatic nerve.
Hirao R; Fujita T; Sakai A; Kumamoto E
Eur J Pharmacol; 2018 Jan; 819():122-128. PubMed ID: 29203420
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity and metalloprotease inhibition of hinokitiol-related compounds, the constituents of Thujopsis dolabrata S. and Z. hondai MAK.
Inamori Y; Shinohara S; Tsujibo H; Okabe T; Morita Y; Sakagami Y; Kumeda Y; Ishida N
Biol Pharm Bull; 1999 Sep; 22(9):990-3. PubMed ID: 10513629
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of opioids on compound action potentials in frog sciatic nerves and their chemical structures.
Mizuta K; Fujita T; Nakatsuka T; Kumamoto E
Life Sci; 2008 Aug; 83(5-6):198-207. PubMed ID: 18593589
[TBL] [Abstract][Full Text] [Related]
8. Prooxidant action of hinokitiol: hinokitiol-iron dependent generation of reactive oxygen species.
Murakami K; Ohara Y; Haneda M; Tsubouchi R; Yoshino M
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):392-4. PubMed ID: 16364055
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of tropolone derivatives and evaluation of their in vitro neuroprotective activity.
Koufaki M; Theodorou E; Alexi X; Nikoloudaki F; Alexis MN
Eur J Med Chem; 2010 Mar; 45(3):1107-12. PubMed ID: 20045220
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by TRPA1 agonists of compound action potentials in the frog sciatic nerve.
Matsushita A; Ohtsubo S; Fujita T; Kumamoto E
Biochem Biophys Res Commun; 2013 Apr; 434(1):179-84. PubMed ID: 23537660
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by capsaicin and its related vanilloids of compound action potentials in frog sciatic nerves.
Tomohiro D; Mizuta K; Fujita T; Nishikubo Y; Kumamoto E
Life Sci; 2013 Mar; 92(6-7):368-78. PubMed ID: 23352977
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production.
Kim DS; Park SH; Kwon SB; Li K; Youn SW; Park KC
Arch Pharm Res; 2004 Mar; 27(3):334-9. PubMed ID: 15089040
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activity of hinokitiol against Legionella pneumophila].
Ishimatsu S; Ohga Y; Ishidao T; Hori H
J UOEH; 2003 Dec; 25(4):435-9. PubMed ID: 14692345
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of alpha-thujaplicin, the isomer of hinokitiol.
Morita Y; Matsumura E; Okabe T; Fukui T; Shibata M; Sugiura M; Ohe T; Tsujibo H; Ishida N; Inamori Y
Biol Pharm Bull; 2004 Jun; 27(6):899-902. PubMed ID: 15187442
[TBL] [Abstract][Full Text] [Related]
15. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
[TBL] [Abstract][Full Text] [Related]
16. Traditional Japanese medicines inhibit compound action potentials in the frog sciatic nerve.
Matsushita A; Fujita T; Ohtsubo S; Kumamoto E
J Ethnopharmacol; 2016 Feb; 178():272-80. PubMed ID: 26707752
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of beta-dolabrin, gamma-thujaplicin, and 4-acetyltropolone, hinokitiol-related compounds.
Morita Y; Matsumura E; Okabe T; Fukui T; Ohe T; Ishida N; Inamori Y
Biol Pharm Bull; 2004 Oct; 27(10):1666-9. PubMed ID: 15467216
[TBL] [Abstract][Full Text] [Related]
18. High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.
Kosugi T; Mizuta K; Fujita T; Nakashima M; Kumamoto E
Br J Pharmacol; 2010 Aug; 160(7):1662-76. PubMed ID: 20649570
[TBL] [Abstract][Full Text] [Related]
19. Tramadol, but not its major metabolite (mono-O-demethyl tramadol) depresses compound action potentials in frog sciatic nerves.
Katsuki R; Fujita T; Koga A; Liu T; Nakatsuka T; Nakashima M; Kumamoto E
Br J Pharmacol; 2006 Oct; 149(3):319-27. PubMed ID: 16921387
[TBL] [Abstract][Full Text] [Related]
20. Transmission electron microscopy of Schistosoma mansoni cercariae treated with hinokitiol (beta-thujaplicin), a compound for potential skin application against cercarial penetration.
Chisty MM; Nargis M; Inaba T; Ishita K; Osanai A; Kamiya H
Tohoku J Exp Med; 2004 Jan; 202(1):63-7. PubMed ID: 14738326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
